Unlock instant, AI-driven research and patent intelligence for your innovation.

Anti-human 4-1 bb antibodies and use thereof

An antibody and antigen technology, applied in the direction of antibodies, antibody medical components, anti-animal/human immunoglobulins, etc., can solve the problems of pain and medical expenses, such as reduced quality of life of cancer patients and their families

Active Publication Date: 2019-10-29
EUTILEX CO LTD
View PDF20 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Additionally, the pain and medical expense of cancer treatment results in a reduced quality of life for cancer patients and their families

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-human 4-1 bb antibodies and use thereof
  • Anti-human 4-1 bb antibodies and use thereof
  • Anti-human 4-1 bb antibodies and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0231] Example 1 - Preparation of humanized anti-human 4-1BB antibody

[0232] This example describes the generation of exemplary anti-human 4-1BB antibodies with improved affinity compared to the reference 94G1 antibody. 94G1 was produced by humanizing the mouse anti-human 4-1BB antibody (BBK 4) as described in Son et al. J. Immunol. Methods (2004) 286:187-201, which is incorporated herein by reference in its entirety. Also used herein is the H4-1BB antigen (accession number: KCTC 0952BP), which is specifically isolated from activated T cells (eg, an activated T cell line) and has not been identified from unstimulated T cells. For example, the H4-1BB antigen can be isolated from T cells that have been matured by phorbol myristate acetate (PMA), ionotoxin, concanavalin A, or anti-CD3i, the H4 The -1BB antigen is 1.4 kb in size and 60% homologous to mouse 4-1BB (Garni-Wagner et al., Cellular Immunology (1996) 169:91-98, which is hereby incorporated by reference in its entirety...

Embodiment 2

[0268] Example 2 - Characterization of humanized anti-human 4-1BB antibodies

[0269] 2.1 Determination of the binding epitope of the anti-human 4-1BB antibody

[0270] It is recognized herein that the humanized anti-human 4-1BB antibodies provided herein can be used for 4-1BB co-stimulation. Therapeutic applications of the antibodies herein may include promoting anti-cancer immunity and / or anti-viral immunity. However, for clinical applications, it is important to identify which portion of human 4-1BB is recognized by and / or reacts with (ie, binding epitope) an anti-humanized 4-1BB antibody. 4-1BB antibodies that recognize different epitopes of the 4-1BB molecule have been identified, and these antibodies have been shown to have diverse clinical effects (see, e.g., Kwon et al. Eur. J. Immunogenetics (2002) 29:449-452, by reference incorporated into this article in its entirety). Epitope mapping includes methods for identifying molecular determinants of antibody-antigen rec...

Embodiment 3

[0294] Example 3 - In Vitro Potency Analysis of Humanized Anti-Human 4-1BB Antibodies

[0295] Anti-4-1BB antibodies have previously been demonstrated to activate CD8 + The co-stimulatory molecule 4-1BB expressed in T cells provides signaling stimulus to activate CD8 + T cells, induce proliferation and increase T H Type 1 cytokine expression. In this example, the humanized anti-4-1BB antibody described in Example 1 was detected to induce CD8 + T cell proliferation and T H Activity of type 1 cytokine expression.

[0296] 3.1 Exemplary anti-human 4-1BB antibodies induce CD8 + Cell Proliferation of T Cells

[0297] To assess CD8 + Proliferation of T cells, cells were stained with WST-1 (water soluble tetrazolium salt), which is a cell proliferation reagent. Preparation of WST-1-labeled CD8 + T cells were activated with 0.5 μg / ml anti-CD3 antibody. activated CD8 + T cells were treated with 1.0 μg / ml of iso-type control antibody, mouse BBK-4 antibody, reference 94G1 anti...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
affinityaaaaaaaaaa
affinityaaaaaaaaaa
absorbanceaaaaaaaaaa
Login to View More

Abstract

Provided are anti-human 4-1BB antibodies and fragments thereof with one or more structural features that are not found in a reference anti-human 4-1BB antibody, where said features may improve certaincharacteristics of the antibody relative to a reference antibody. Various in vitro and in vivo methods and reagents related to anti-human 4-1BB antibodies described herein are also provided. Methodsinclude, for example, inducing T-cell proliferation, inducing T cell secretion of IFN[gamma], as well as detection, prevention, and / or therapeutic treatment of cancer using an anti-human 4-1BB antibody or fragment thereof.

Description

[0001] Related Application Cross Reference [0002] This application claims the benefit of priority to U.S. Patent Application No. 62 / 443,281, filed January 6, 2017, the disclosure of which is incorporated herein by reference in its entirety. Background technique [0003] Cancer is still one of the leading causes of death in the world. Recent statistics report that 13% of the global population dies from cancer. According to the estimates of the International Agency for Research on Cancer (IARC), there were 14.1 million new cancer cases and 8.2 million cancer deaths worldwide in 2012. The global burden is projected to increase to 21.7 million new cancer cases and 13 million cancer deaths by 2030 due to population growth and aging and exposure to risk factors such as smoking, unhealthy diet and physical inactivity. In addition, the pain and medical expenses of cancer treatment lead to a reduced quality of life for cancer patients and their families. It is clear that cancer i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K16/28A61K39/395A61P35/00A61P37/04
CPCC07K16/2878C07K2317/565A61P37/04A61P35/00C07K16/2818A61K2039/505A61K2039/507C07K2317/76C07K2317/24C07K2317/515C07K2317/75C07K2317/92C07K2317/567C07K2317/34C07K16/28C12N5/0636A61K35/17C07K2317/51A61K39/3955A61K39/39558A61K45/06A61K39/395
Inventor 权炳世李承柱金永昊吴好植李重远
Owner EUTILEX CO LTD